Branded Legacy, Inc. Reports
Significant Net Income of Over $3.8 Million
Growth and Strategic Expansions
in 2024 With Over $3.7 Million In Assets
MELBOURNE, FL -- April 16,
2024 -- InvestorsHub NewsWire -- Branded Legacy, Inc,
(OTC.PK:
BLEG) a leading provider of innovative wellness
products, is pleased to announce a net income for the fiscal year
2023 of $3,825,527, a substantial increase driven by the strategic
retirement of over 2.4 billion shares. As they forge into 2024, the
company has signed multiple on-going white label contracts, poised
to further enhance our revenue and profitability for the coming
year and beyond.
"2023 was a year of
substantial growth and strategic repositioning for Branded Legacy.
As we continue to expand and innovate, our focus remains steadfast
on leveraging our core strengths in biotechnology to improve human
health globally," said David Oswald, CEO of Branded
Legacy.
In a remarkable
development, Branded Legacy has welcomed Dr. Mark T. Hamann, the
Endowed Chair of Drug Discovery and Biomedical Sciences at the MUSC
College of Pharmacy, to guide its forthcoming clinical trials. This
follows the Company's recent strategic acquisition of Sycamore
BioPharma, Inc., a distinguished developer of plant-based
pharmaceuticals. This acquisition not only secured assets exceeding
$2 million but also integrates key personnel vital for advancing
their clinical trials.
The company's recent
strategic endeavors include the acquisition of several companies,
bringing over $3.7 million worth of advanced scientific equipment
and inventory. This expansion has necessitated a move to a larger,
state-of-the-art facility in Melbourne, FL, to accommodate their
growing operations and align with their commitment to
biotechnological advancement and improving human health.
The Company's total assets
have seen an astronomical increase to $3,787,215.00, the majority
in 2024, marking a 1,412% increase compared to the end of Q3. The
newly acquired laboratory and packaging equipment significantly
bolsters capacities in R&D, production, and
packaging.
The extensive equipment
range acquired includes High-Performance Liquid Chromatography and
Gas Chromatography systems, various centrifuges, vacuum ovens, an
irradiating flow hood, incubators, and more. This arsenal of
advanced tools empowers the Company to conduct precise chemical
analyses, foster controlled research environments, and enhance
product development efficiency across various stages.
Furthering its expansion
strategy, Branded Legacy, Inc. proudly announced its acquisition of
MariJ Pharmaceuticals, Inc. This deal significantly broadens their
asset base and intellectual property portfolio, integrating a
compounding pharmacy license, state-of-the-art supercritical CO2
extraction units, and a fleet of specialized vehicles designed for
mobile extraction and refinement.
This strategic acquisition
delivers not only a suite of award-winning organic products and
formulations but also enhances their operational flexibility and
market reach through the addition of specialized vehicles and a
mobile repair service. These assets are instrumental in maintaining
the efficiency and reach of our operations across multiple states,
including Colorado and Tennessee.
The acquisition of All In
Extracts Llc. gave Branded Legacy a leg up in production of
gummies, producing 20-50,000 units
daily. The All In facility near
Tampa, FL, has recently staged up production and refinement of
mitragynine, as well as production of a proprietary dosing
syrup. With several popular
products under their Star Hill brand, All In Extracts is a core
aspect of Branded Legacy's growing revenue.
Branded Legacy, Inc. is
poised to continue its trajectory of growth, innovation, and market
leadership in the biotech and wellness industries.
Original Copy of this Press Release:
https://brandedlegacy.com/branded-legacy-inc-reports-significant-net-income/
For Investor Relations
& Media Contact:
Joe Holladay
Branded Legacy
Phone:
321-345-3565
Email: info@brandedlegacy.com
Website: https://brandedlegacy.com/
About Branded Legacy,
Inc.:
Branded Legacy, Inc. (OTC:
BLEG) is a diversified holdings company focused on the biotech
sector. With a commitment to excellence and innovation, Branded
Legacy specializes in the development and marketing of cutting-edge
products and services, including ventures in biotechnology, digital
solutions, and wellness products.
Safe Harbor Statement on
Forward-Looking Language:
This release includes
forward-looking statements, subject to risks and uncertainties that
could cause actual results to differ materially from current
expectations. The company disclaims any intention or obligation to
update or revise forward-looking statements. Forward-looking
statements may be identified by words such as "may," "will,"
"expect," "believe," "anticipate," "estimate," and similar
expressions.
